A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety ofSotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapyfor the Treatment of PAH

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
StatusFinished
Effective start/end date3/1/213/31/24

Funding

  • ACCELERON PHARMA INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.